ENTITY

Physiomics (PYC LN)

34
Analysis
Industrials • United Kingdom
Physiomics is a data-driven consultancy that provides Model-Informed Drug Development (MIDD), Biostatistics, Statistical Programming, and Bioinformatics solutions to biopharmaceutical companies and research institutes. The company utilizes its proprietary Virtual Tumour technology platform to optimize the design of cancer clinical trials and predict the effects of treatments. Physiomics was founded in 2001 and is headquartered in Abingdon, United Kingdom.
more
bullish•Van Elle
•22 Dec 2025 19:02•Issuer-paid

Van Elle Holdings PLC - Friday Take Away: 15 December 2025

The Company bridges traditional finance and digital assets through a relationship-led fintech platform designed for institutional and professional...

Logo
Hybridan
328 Views
Share
•18 Dec 2025 22:00•Issuer-paid

Strategic Minerals PLC - Hybridan Small Cap Feast: 11 December 2025

East Star Resources 3.55p £13.26m (EST.L) The Kazakhstan-focused gold and base metals explorer has announced it has signed binding Heads of...

Logo
Hybridan
265 Views
Share
•18 Dec 2025 07:31•Issuer-paid

Hybridan Small Cap Feast: 10 December 2025

Aptitude Software Group 293p £161.44m (APTD.L) The provider of finance transformation software solutions specialising in fully autonomous finance...

Logo
Hybridan
177 Views
Share
•11 Dec 2025 23:17•Issuer-paid

Hybridan Small Cap Feast: 3 December 2025

The Company is in the process of clearing out the blast material from the previous test blast and making other final preparations in readiness to...

Logo
Hybridan
247 Views
Share
•08 Oct 2025 01:02•Issuer-paid

Seraphim Space Investment Trust PLC - Hybridan Monthly, 1 October 2025

Whilst many will always be taken in by the allure of brighter colours, louder engines, and slender appearance, there are some that will stay loyal...

Logo
Hybridan
248 Views
Share
x